How long is a Covid-19 (Coronavirus disease 2019) infected person contagious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of COVID-19 Contagiousness

A COVID-19 infected person is contagious for an average of 10 days from symptom onset in mild-to-moderate cases, but two-thirds remain infectious at day 5 and nearly one-quarter at day 7, with extended periods up to 15-20 days in severe or immunocompromised patients. 1

Timing of Peak Infectiousness

  • Infectiousness begins 1-2 days BEFORE symptom onset, making pre-symptomatic transmission a critical feature distinguishing COVID-19 from many other respiratory infections 1, 2
  • Peak viral shedding occurs within the first 7 days of illness, with the highest contagiousness in the 2 days before and 5 days after symptom onset 2, 1
  • Live virus remains detectable in the respiratory tract for up to 9 days in most individuals 1

Duration by Disease Severity

Mild-to-Moderate Disease

  • Self-isolation should be 10 days from symptom onset for patients with mild-to-moderate disease 2
  • The median duration of infectious viral shedding is 5 days (range 3-7 days) from symptom onset 3
  • However, 65% of cases continue shedding infectious virus at day 5, and 24% remain infectious at day 7 post-symptom onset 3
  • Replication-competent virus is rarely cultured beyond 10 days after symptom onset 2, 4

Severe/Critical Disease

  • Self-isolation should extend to 15-20 days for severely ill patients 2
  • The risk of replication-competent virus is approximately 5% at 15 days after symptom onset and extremely rare at 20 days 2
  • Viral shedding extends beyond 2 weeks in severe cases 1
  • The longest documented interval with replication-competent virus is 20 days from symptom onset 4

Immunocompromised Patients

  • Isolation should extend to at least 20 days or longer following symptom onset in severely immunocompromised patients 2, 1
  • Infectivity may continue for extended periods in this population 2
  • Specialist advice on duration of self-isolation may be needed 2

Critical Pitfalls to Avoid

  • Do NOT use PCR testing to determine end of isolation - PCR positivity does not correlate with secretion of live virus and can remain positive for weeks to months after infectiousness has ended 2
  • Viral RNA remains detectable in half of patients 21-30 days after symptom onset, but this does not indicate infectiousness 5
  • Do NOT rely on symptom resolution alone - patients may remain infectious despite symptom improvement 3

Practical Isolation Guidance

  • For mild-moderate symptomatic patients: Isolate for 10 days from symptom onset PLUS at least 24 hours fever-free without antipyretics PLUS improvement in other symptoms 2
  • For severe cases: Extend isolation to 15-20 days from symptom onset 2
  • For immunocompromised patients: Minimum 20 days isolation, potentially longer with specialist consultation 2, 1
  • For asymptomatic cases who test positive: 10 days from positive test date 2

Asymptomatic Transmission Considerations

  • Approximately 30-60% of patients shedding virus may have no symptoms 1
  • Only 20% of cases shed infectious virus pre-symptomatically, though 63% have PCR-detectable virus before symptom onset 3
  • This explains why symptom-based screening alone is insufficient for infection control 1

Role of Antigen Testing

  • Nucleocapsid (N) antigen testing strongly correlates with culture positivity (relative risk 7.61) and is a better predictor of infectiousness than viral RNA or symptoms 5
  • Lateral flow devices show poor sensitivity (67%) during viral growth phase but high sensitivity (92%) during decline phase 3
  • N antigen may be more suitable than PCR or symptom assessment for determining safe deisolation within two weeks of symptom onset 5

References

Guideline

COVID-19 Infectious Window and Transmission

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Research

Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.